AtaiBeckley (ATAI) Non-Current Debt (2022 - 2025)
AtaiBeckley (ATAI) posted quarterly Non-Current Debt of $14.1 million for Q4 2024.
Analysis
AtaiBeckley (ATAI) Non-Current Debt (2022 - 2025) Analysis & Trends
AtaiBeckley's Non-Current Debt history runs 1 years deep, the most recent figure standing at $14.1 million for Q4 2024.
- Quarterly Non-Current Debt fell 38.57% year-over-year to $9.3 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $9.3 million (down 38.57% YoY) and the FY2024 annual result came in at $20.5 million, up 36.29% from the prior year.
- Non-Current Debt slipped to $9.3 million in Q1 2025 per ATAI's latest filing, from $20.5 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $20.5 million in Q4 2024 and troughed at $9.3 million in Q1 2025.
- A 4-year average of $15.4 million and a median of $15.0 million in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt surged 36.29% in 2024, then sank 38.57% in 2025.
- Over 4 years, Non-Current Debt stood at $14.7 million in 2022, then gained by 2.35% to $15.0 million in 2023, then soared by 36.29% to $20.5 million in 2024, then plunged by 54.65% to $9.3 million in 2025.
- According to Business Quant data, Non-Current Debt over the past three periods registered $9.3 million, $20.5 million, and $20.3 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 591.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 882.16 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 8.96 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 546.77 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 20.67 Mn |
| Dec 31, 2024 | 20.51 Mn |
| Dec 31, 2024 | 14.13 Mn |
| Sep 30, 2024 | 20.34 Mn |
| Jun 30, 2024 | 15.24 Mn |
| Mar 31, 2024 | 15.14 Mn |
| Dec 31, 2023 | 15.05 Mn |
| Sep 30, 2023 | 14.96 Mn |
| Jun 30, 2023 | 14.87 Mn |
| Mar 31, 2023 | 14.78 Mn |
| Dec 31, 2022 | 14.70 Mn |
| Sep 30, 2022 | 14.62 Mn |